Skip to main content
. 2022 Sep 15;13:5413. doi: 10.1038/s41467-022-33116-z

Fig. 5. UBA6 deletion substitutes the effect of inosine on antitumour immunity in vivo.

Fig. 5

a Tumour volume and survival analysis of sgCtrl and sgUba6 B16-GMCSF tumours in NSG, wild-type (WT) mice (n = 8). b Tumour volume and survival analysis of sgCtrl and sgUba6 B16-GMCSF tumours in WT mice with Ctrl, ICB, or ICB + Ino treatment (n = 8). c Tumour volume and survival analysis of sgCtrl and sgUba6 4T1 tumour-bearing NSG mice (left) or wild-type (WT) mice (right) (n = 10). d Tumour volume and survival analysis of sgCtrl and sgUba6 4T1 tumour-bearing WT mice with Ctrl, ICB, or ICB + Ino treatment (n = 10). Data are presented as mean ± SEM. Statistical significance was determined by ANOVA (tumour volume of ad) or log-rank (Mantel–Cox) test (survival analysis of ad). NS no significant. Source data are provided as a Source Data file.